Variation  ||| S:0 E:10 ||| NN
in  ||| S:10 E:13 ||| IN
provider  ||| S:13 E:22 ||| NN
vaccine  ||| S:22 E:30 ||| NN
purchase  ||| S:30 E:39 ||| NN
prices  ||| S:39 E:46 ||| NNS
and  ||| S:46 E:50 ||| CC
payer  ||| S:50 E:56 ||| JJ
reimbursement  ||| S:56 E:70 ||| NN
The  ||| S:70 E:74 ||| DT
purpose  ||| S:74 E:82 ||| NN
of  ||| S:82 E:85 ||| IN
this  ||| S:85 E:90 ||| DT
work  ||| S:90 E:95 ||| NN
was  ||| S:95 E:99 ||| VBD
to  ||| S:99 E:102 ||| TO
collect  ||| S:102 E:110 ||| VB
data  ||| S:110 E:115 ||| NNS
regarding  ||| S:115 E:125 ||| VBG
vaccine  ||| S:125 E:133 ||| NN
prices  ||| S:133 E:140 ||| NNS
and  ||| S:140 E:144 ||| CC
reimbursements  ||| S:144 E:159 ||| NNS
in  ||| S:159 E:162 ||| IN
private  ||| S:162 E:170 ||| JJ
practices ||| S:170 E:179 ||| NNS
.  ||| S:179 E:181 ||| .
Amid  ||| S:181 E:186 ||| IN
reports  ||| S:186 E:194 ||| NNS
of  ||| S:194 E:197 ||| IN
physicians  ||| S:197 E:208 ||| NNS
losing  ||| S:208 E:215 ||| VBG
money  ||| S:215 E:221 ||| NN
on  ||| S:221 E:224 ||| IN
vaccines ||| S:224 E:232 ||| NNS
,  ||| S:232 E:234 ||| ,
there  ||| S:234 E:240 ||| EX
are  ||| S:240 E:244 ||| VBP
limited  ||| S:244 E:252 ||| VBN
supporting  ||| S:252 E:263 ||| VBG
data  ||| S:263 E:268 ||| NNS
to  ||| S:268 E:271 ||| TO
show  ||| S:271 E:276 ||| VB
how  ||| S:276 E:280 ||| WRB
much  ||| S:280 E:285 ||| JJ
private  ||| S:285 E:293 ||| JJ
practices  ||| S:293 E:303 ||| NNS
are  ||| S:303 E:307 ||| VBP
paying  ||| S:307 E:314 ||| VBG
for  ||| S:314 E:318 ||| IN
vaccines  ||| S:318 E:327 ||| NNS
and  ||| S:327 E:331 ||| CC
how  ||| S:331 E:335 ||| WRB
much  ||| S:335 E:340 ||| RB
they  ||| S:340 E:345 ||| PRP
are  ||| S:345 E:349 ||| VBP
being  ||| S:349 E:355 ||| VBG
reimbursed  ||| S:355 E:366 ||| VBN
by  ||| S:366 E:369 ||| IN
third-party  ||| S:369 E:381 ||| JJ
payers ||| S:381 E:387 ||| NNS
.  ||| S:387 E:389 ||| .
We  ||| S:389 E:392 ||| PRP
conducted  ||| S:392 E:402 ||| VBD
a  ||| S:402 E:404 ||| DT
cross-sectional  ||| S:404 E:420 ||| JJ
survey  ||| S:420 E:427 ||| NN
of  ||| S:427 E:430 ||| IN
a  ||| S:430 E:432 ||| DT
convenience  ||| S:432 E:444 ||| NN
sample  ||| S:444 E:451 ||| NN
of  ||| S:451 E:454 ||| IN
private  ||| S:454 E:462 ||| JJ
practices  ||| S:462 E:472 ||| NNS
in  ||| S:472 E:475 ||| IN
5  ||| S:475 E:477 ||| CD
states  ||| S:477 E:484 ||| NNS
( ||| S:484 E:485 ||| -LRB-
California ||| S:485 E:495 ||| NNP
,  ||| S:495 E:497 ||| ,
Georgia ||| S:497 E:504 ||| NNP
,  ||| S:504 E:506 ||| ,
Michigan ||| S:506 E:514 ||| NNP
,  ||| S:514 E:516 ||| ,
New  ||| S:516 E:520 ||| NNP
York ||| S:520 E:524 ||| NNP
,  ||| S:524 E:526 ||| ,
and  ||| S:526 E:530 ||| CC
Texas ||| S:530 E:535 ||| NNP
)  ||| S:535 E:537 ||| -RRB-
that  ||| S:537 E:542 ||| IN
purchase  ||| S:542 E:551 ||| NN
vaccines  ||| S:551 E:560 ||| NNS
for  ||| S:560 E:564 ||| IN
administration  ||| S:564 E:579 ||| NN
to  ||| S:579 E:582 ||| TO
privately  ||| S:582 E:592 ||| RB
insured  ||| S:592 E:600 ||| JJ
children ||| S:600 E:608 ||| NNS
/ ||| S:608 E:609 ||| CD
adolescents ||| S:609 E:620 ||| NNS
.  ||| S:620 E:622 ||| .
Main  ||| S:622 E:627 ||| JJ
outcome  ||| S:627 E:635 ||| NN
measures  ||| S:635 E:644 ||| NNS
included  ||| S:644 E:653 ||| VBD
prices  ||| S:653 E:660 ||| NNS
paid  ||| S:660 E:665 ||| VBN
to  ||| S:665 E:668 ||| TO
purchase  ||| S:668 E:677 ||| VB
vaccines  ||| S:677 E:686 ||| NNS
recommended  ||| S:686 E:698 ||| VBD
for  ||| S:698 E:702 ||| IN
children  ||| S:702 E:711 ||| NNS
and  ||| S:711 E:715 ||| CC
adolescents  ||| S:715 E:727 ||| NNS
and  ||| S:727 E:731 ||| CC
reimbursement  ||| S:731 E:745 ||| NN
from  ||| S:745 E:750 ||| IN
the  ||| S:750 E:754 ||| DT
3  ||| S:754 E:756 ||| CD
most  ||| S:756 E:761 ||| RBS
common ||| S:761 E:767 ||| JJ
,  ||| S:767 E:769 ||| ,
non-Medicaid  ||| S:769 E:782 ||| JJ
payers  ||| S:782 E:789 ||| NNS
for  ||| S:789 E:793 ||| IN
vaccine  ||| S:793 E:801 ||| NN
purchase  ||| S:801 E:810 ||| NN
and  ||| S:810 E:814 ||| CC
administration ||| S:814 E:828 ||| NN
.  ||| S:828 E:830 ||| .
Detailed  ||| S:830 E:839 ||| JJ
price  ||| S:839 E:845 ||| NN
and  ||| S:845 E:849 ||| CC
reimbursement  ||| S:849 E:863 ||| JJ
data  ||| S:863 E:868 ||| NNS
were  ||| S:868 E:873 ||| VBD
provided  ||| S:873 E:882 ||| VBN
by  ||| S:882 E:885 ||| IN
76  ||| S:885 E:888 ||| CD
practices ||| S:888 E:897 ||| NNS
.  ||| S:897 E:899 ||| .
There  ||| S:899 E:905 ||| EX
was  ||| S:905 E:909 ||| VBD
a  ||| S:909 E:911 ||| DT
considerable  ||| S:911 E:924 ||| JJ
difference  ||| S:924 E:935 ||| NN
between  ||| S:935 E:943 ||| IN
the  ||| S:943 E:947 ||| DT
maximum  ||| S:947 E:955 ||| NN
and  ||| S:955 E:959 ||| CC
minimum  ||| S:959 E:967 ||| JJ
prices  ||| S:967 E:974 ||| NNS
paid  ||| S:974 E:979 ||| VBN
by  ||| S:979 E:982 ||| IN
practices ||| S:982 E:991 ||| NNS
,  ||| S:991 E:993 ||| ,
ranging  ||| S:993 E:1001 ||| VBG
from  ||| S:1001 E:1006 ||| IN
$ ||| S:1006 E:1007 ||| $
4  ||| S:1007 E:1009 ||| CD
to  ||| S:1009 E:1012 ||| TO
more  ||| S:1012 E:1017 ||| JJR
than  ||| S:1017 E:1022 ||| IN
$ ||| S:1022 E:1023 ||| $
30  ||| S:1023 E:1026 ||| CD
for  ||| S:1026 E:1030 ||| IN
specific  ||| S:1030 E:1039 ||| JJ
vaccines ||| S:1039 E:1047 ||| NNS
.  ||| S:1047 E:1049 ||| .
There  ||| S:1049 E:1055 ||| EX
was  ||| S:1055 E:1059 ||| VBD
also  ||| S:1059 E:1064 ||| RB
significant  ||| S:1064 E:1076 ||| JJ
variation  ||| S:1076 E:1086 ||| NN
in  ||| S:1086 E:1089 ||| IN
insurance  ||| S:1089 E:1099 ||| NN
reimbursement  ||| S:1099 E:1113 ||| NN
for  ||| S:1113 E:1117 ||| IN
vaccine  ||| S:1117 E:1125 ||| NN
purchase ||| S:1125 E:1133 ||| NN
,  ||| S:1133 E:1135 ||| ,
with  ||| S:1135 E:1140 ||| IN
maximum  ||| S:1140 E:1148 ||| NN
and  ||| S:1148 E:1152 ||| CC
minimum  ||| S:1152 E:1160 ||| JJ
reimbursements  ||| S:1160 E:1175 ||| NNS
for  ||| S:1175 E:1179 ||| IN
a  ||| S:1179 E:1181 ||| DT
single  ||| S:1181 E:1188 ||| JJ
vaccine  ||| S:1188 E:1196 ||| NN
differing  ||| S:1196 E:1206 ||| VBG
from  ||| S:1206 E:1211 ||| IN
$ ||| S:1211 E:1212 ||| $
8  ||| S:1212 E:1214 ||| CD
to  ||| S:1214 E:1217 ||| TO
more  ||| S:1217 E:1222 ||| JJR
than  ||| S:1222 E:1227 ||| IN
$ ||| S:1227 E:1228 ||| $
80 ||| S:1228 E:1230 ||| CD
.  ||| S:1230 E:1232 ||| .
Mean  ||| S:1232 E:1237 ||| VB
net  ||| S:1237 E:1241 ||| JJ
yield  ||| S:1241 E:1247 ||| NN
per  ||| S:1247 E:1251 ||| IN
dose  ||| S:1251 E:1256 ||| NN
( ||| S:1256 E:1257 ||| -LRB-
reimbursement  ||| S:1257 E:1271 ||| NN
for  ||| S:1271 E:1275 ||| IN
vaccine  ||| S:1275 E:1283 ||| NN
purchase  ||| S:1283 E:1292 ||| NN
minus  ||| S:1292 E:1298 ||| CC
price  ||| S:1298 E:1304 ||| NN
paid  ||| S:1304 E:1309 ||| VBN
per  ||| S:1309 E:1313 ||| IN
dose ||| S:1313 E:1317 ||| NN
)  ||| S:1317 E:1319 ||| -RRB-
varied  ||| S:1319 E:1326 ||| VBD
across  ||| S:1326 E:1333 ||| IN
vaccines  ||| S:1333 E:1342 ||| NNS
from  ||| S:1342 E:1347 ||| IN
a  ||| S:1347 E:1349 ||| DT
low  ||| S:1349 E:1353 ||| JJ
of  ||| S:1353 E:1356 ||| IN
approximately  ||| S:1356 E:1370 ||| RB
$ ||| S:1370 E:1371 ||| $
3  ||| S:1371 E:1373 ||| CD
to  ||| S:1373 E:1376 ||| TO
more  ||| S:1376 E:1381 ||| JJR
than  ||| S:1381 E:1386 ||| IN
$ ||| S:1386 E:1387 ||| $
24 ||| S:1387 E:1389 ||| CD
.  ||| S:1389 E:1391 ||| .
Reimbursement  ||| S:1391 E:1405 ||| NN
for  ||| S:1405 E:1409 ||| IN
the  ||| S:1409 E:1413 ||| DT
first  ||| S:1413 E:1419 ||| JJ
dose  ||| S:1419 E:1424 ||| NN
of  ||| S:1424 E:1427 ||| IN
vaccine  ||| S:1427 E:1435 ||| NN
administered  ||| S:1435 E:1448 ||| VBN
ranged  ||| S:1448 E:1455 ||| VBN
from  ||| S:1455 E:1460 ||| IN
$ ||| S:1460 E:1461 ||| $
0  ||| S:1461 E:1463 ||| CD
to  ||| S:1463 E:1466 ||| TO
more  ||| S:1466 E:1471 ||| JJR
than  ||| S:1471 E:1476 ||| IN
$ ||| S:1476 E:1477 ||| $
26 ||| S:1477 E:1479 ||| CD
,  ||| S:1479 E:1481 ||| ,
with  ||| S:1481 E:1486 ||| IN
a  ||| S:1486 E:1488 ||| DT
mean  ||| S:1488 E:1493 ||| NN
of  ||| S:1493 E:1496 ||| IN
$ ||| S:1496 E:1497 ||| $
16.62 ||| S:1497 E:1502 ||| CD
.  ||| S:1502 E:1504 ||| .
There  ||| S:1504 E:1510 ||| EX
is  ||| S:1510 E:1513 ||| VBZ
a  ||| S:1513 E:1515 ||| DT
wide  ||| S:1515 E:1520 ||| JJ
range  ||| S:1520 E:1526 ||| NN
of  ||| S:1526 E:1529 ||| IN
prices  ||| S:1529 E:1536 ||| NNS
paid  ||| S:1536 E:1541 ||| VBN
by  ||| S:1541 E:1544 ||| IN
practices  ||| S:1544 E:1554 ||| NNS
for  ||| S:1554 E:1558 ||| IN
the  ||| S:1558 E:1562 ||| DT
same  ||| S:1562 E:1567 ||| JJ
vaccine  ||| S:1567 E:1575 ||| NN
product  ||| S:1575 E:1583 ||| NN
and  ||| S:1583 E:1587 ||| CC
in  ||| S:1587 E:1590 ||| IN
the  ||| S:1590 E:1594 ||| DT
reimbursement  ||| S:1594 E:1608 ||| NN
for  ||| S:1608 E:1612 ||| IN
vaccines  ||| S:1612 E:1621 ||| NNS
and  ||| S:1621 E:1625 ||| CC
administration  ||| S:1625 E:1640 ||| NN
fees  ||| S:1640 E:1645 ||| NNS
by  ||| S:1645 E:1648 ||| IN
payers ||| S:1648 E:1654 ||| NNS
.  ||| S:1654 E:1656 ||| .
This  ||| S:1656 E:1661 ||| DT
variation  ||| S:1661 E:1671 ||| NN
highlights  ||| S:1671 E:1682 ||| VBZ
the  ||| S:1682 E:1686 ||| DT
need  ||| S:1686 E:1691 ||| NN
for  ||| S:1691 E:1695 ||| IN
individual  ||| S:1695 E:1706 ||| JJ
practices  ||| S:1706 E:1716 ||| NNS
to  ||| S:1716 E:1719 ||| TO
understand  ||| S:1719 E:1730 ||| VB
their  ||| S:1730 E:1736 ||| PRP$
own  ||| S:1736 E:1740 ||| JJ
costs  ||| S:1740 E:1746 ||| NNS
and  ||| S:1746 E:1750 ||| CC
reimbursements  ||| S:1750 E:1765 ||| NNS
and  ||| S:1765 E:1769 ||| CC
to  ||| S:1769 E:1772 ||| TO
seek  ||| S:1772 E:1777 ||| VB
opportunities  ||| S:1777 E:1791 ||| NNS
to  ||| S:1791 E:1794 ||| TO
reduce  ||| S:1794 E:1801 ||| VB
costs  ||| S:1801 E:1807 ||| NNS
and  ||| S:1807 E:1811 ||| CC
increase  ||| S:1811 E:1820 ||| NN
reimbursements ||| S:1820 E:1834 ||| NNS
.  ||| S:1834 E:1836 ||| .
